COM:ALXONCOLOGY

ALX Oncology Holdings Inc.

Stock

USD

Last Close

1.29

22/11 21:00

Market Cap

352.20M

Beta: -

Volume Today

966.09K

Avg: -

Overview Analysis Metrics Financials Filings API Chart Data

Income Statement Balance Sheet Cash Flow Key Metrics Ratios

Quarterly

Yearly

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe Now Help

	Dec '18	Dec '19	Dec '20	Dec '21	Dec '22	Dec '23
net income	-13.73M -	-19.24M 40.14%	-45.74M 137.70%	-83.46M 82.47%	-123.48M 47.95%	-160.81M 30.23%
depreciation and amortization	431K -	429K 0.46%	202K 52.91%	51K 74.75%	342K 570.59%	836K 144.44%
deferred income tax			1.27M -			-458K -
stock based compensation	269K -	297K 10.41%	5.44M 1,730.30%	13.91M 155.96%	23.84M 71.33%	26.27M 10.21%
change in working capital	-159K -	4.26M 2,777.36%	247K 94.20%	-4.03M 1,730.36%	9.85M 344.60%	8.30M 15.77%
accounts receivables		396K -	536K 35.35%
inventory		-396K -	-536K 35.35%
accounts payables	-269K -	2.98M 1,206.32%	-3.74M 225.81%	3.29M 187.87%	4.51M 36.96%	458K 89.84%
other working capital	110K -	1.28M 1,064.55%	3.99M 211.55%	-7.32M 283.34%	5.34M 173.04%	7.84M 46.69%
other non cash items		11K -	295K 2,581.82%	5.42M 1,738.64%	228K 95.80%	-4.51M 2,076.75%
net cash provided by operating activities	-13.19M -	-14.25M 8.03%	-38.29M 168.71%	-68.10M 77.86%	-89.22M 31.02%	-130.36M 46.11%
investments in property plant and equipment	-653K -	-353K 45.94%	-31K 91.22%	-4.92M 15,780.65%	-1.43M 71.01%	-1.27M 10.72%
acquisitions net			641K -		233.99K -
purchases of investments					-376.79M -	-246.63M 34.54%
sales maturities of investments					142.80M -	292.56M 104.87%
other investing activites					-233.99K -
net cash used for investing activites	-653K -	-353K 45.94%	610K 272.80%	-4.92M 907.05%	-235.42M 4,681.96%	44.66M 118.97%
debt repayment			-6.51M -	-281K 95.68%	-388K 38.08%	-388K 0%
common stock issued	7K -	10K 42.86%	368.26M 3,682,460%	2.75M 99.25%	567K 79.40%	59.68M 10,425.40%
common stock repurchased	-6K -		3K -	202K 6,633.33%	336K 66.34%	523K 55.65%
dividends paid			-3K -	-2.75M 91,666.67%		-59.68M -
other financing activites		15.35M -	101.13M 558.96%	2.55M 97.48%	9.35M 266.33%	59.16M 533.02%
net cash used provided by financing activities	1K -	15.36M 1,535,600%	462.88M 2,914.14%	2.47M 99.47%	9.86M 298.87%	59.29M 501.33%
effect of forex changes on cash
net change in cash	-13.84M -	755K 105.45%	425.20M 56,218.15%	-70.55M 116.59%	-314.78M 346.17%	-26.42M 91.61%
cash at beginning of period	22.10M -	8.26M 62.62%	9.02M 9.14%	434.22M 4,715.56%	363.67M 16.25%	48.82M 86.58%
cash at end of period	8.26M -	9.02M 9.14%	434.22M 4,715.56%	363.67M 16.25%	48.89M 86.56%	22.41M 54.17%
operating cash flow	-13.19M -	-14.25M 8.03%	-38.29M 168.71%	-68.10M 77.86%	-89.22M 31.02%	-130.36M 46.11%
capital expenditure	-653K -	-353K 45.94%	-31K 91.22%	-4.92M 15,780.65%	-1.43M 71.01%	-1.27M 10.72%
free cash flow	-13.84M -	-14.60M 5.48%	-38.32M 162.43%	-73.02M 90.56%	-90.65M 24.14%	-131.64M 45.22%

All numbers in USD (except ratios and percentages)